Critical Chats
Podcast Description
A glimpse into the providers behind the medicine and the latest developments in the critical care world. Join us for all things critical care every month!
Podcast Insights
Content Themes
The podcast focuses on critical care topics, with episodes dedicated to discussions around sepsis, emergency medicine innovations, and pulmonary care. For instance, the inaugural episode features Dr. Mullen highlighting his expertise on sepsis, discussing recent studies and treatment advancements, such as early vasopressin and high dose hydroxycobalamin therapies.

A glimpse into the providers behind the medicine and the latest developments in the critical care world. Join us for all things critical care every month!
Checkout our playlist of anthem songs curated by our guests:
https://open.spotify.com/playlist/1OnPaXbFpKz4dX8llX3fEy?si=-tyRNy_JTA2xdaRDiffHUQ
Today we are joined by Dr. Raphael Carandang, a neurocritical care physician who cares for patients facing life-altering neurological emergencies — from severe strokes to traumatic brain injuries — where minutes matter and decisions can define outcomes.
In this episode, we break down what really happens after a traumatic brain injury, how critical care teams monitor and protect the brain in real time, and why individualized, data-driven treatment is reshaping outcomes. We’ll also explore the BOOST protocol — what it is, how it guides brain oxygen monitoring, and how it’s changing the way clinicians approach secondary brain injury.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.